Label Changes for:
Nizoral (ketoconazole) 2% shampoo
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
Information for Patients
- The following have been reported with the use of Nizoral (ketoconazole) 2% Shampoo: angioedema
- Patients who develop allergic reactions, such as angioedema
- Induced emesis and gastric lavage should not be performed to avoid aspiration.